Picard Medical, Inc.
PMI
$7.60
$0.000.00%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -25.84% | -5.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.84% | -5.11% | |||
| Cost of Revenue | 39.71% | -54.95% | |||
| Gross Profit | -363.24% | 120.21% | |||
| SG&A Expenses | -28.74% | 3.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.30% | -17.22% | |||
| Operating Income | 9.13% | 19.62% | |||
| Income Before Tax | 37.54% | -42.65% | |||
| Income Tax Expenses | 306.67% | -- | |||
| Earnings from Continuing Operations | 37.08% | -42.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.08% | -42.41% | |||
| EBIT | 9.13% | 19.62% | |||
| EBITDA | 9.24% | 19.81% | |||
| EPS Basic | 33.48% | -38.04% | |||
| Normalized Basic EPS | 37.70% | -42.66% | |||
| EPS Diluted | 33.48% | -38.04% | |||
| Normalized Diluted EPS | 37.70% | -42.66% | |||
| Average Basic Shares Outstanding | 0.25% | -0.01% | |||
| Average Diluted Shares Outstanding | 0.25% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||